journal article·2016-08-02Open access

pH-Responsive PLGA Nanoparticle for Controlled Payload Delivery of Diclofenac Sodium

Shalil Khanal, Udhab Adhikari, Nava Rijal, Shanta Bhattarai, Jagannathan Sankar, Narayan Bhattarai

Abstract

Poly(lactic-co-glycolic acid) (PLGA) based nanoparticles have gained increasing attention in delivery applications due to their capability for controlled drug release characteristics, biocompatibility, and tunable mechanical, as well as degradation, properties. However, thorough study is always required while evaluating potential toxicity of the particles from dose dumping, inconsistent release and drug-polymer interactions. In this research, we developed PLGA nanoparticles modified by chitosan (CS), a cationic and pH responsive polysaccharide that bears repetitive amine groups in its backbone. We used a model drug, diclofenac sodium (DS), a nonsteroidal anti-inflammatory drug (NSAID), to study the drug loading and release characteristics. PLGA nanoparticles were synthesized by double-emulsion solvent evaporation technique. The nanoparticles were evaluated based on their particle size, surface charge, entrapment efficacy, and effect of pH in drug release profile. About 390–420 nm of average diameters and uniform morphology of the particles were confirmed by scanning electron microscope (SEM) imaging and dynamic light scattering (DLS) measurement. Chitosan coating over PLGA surface was confirmed by FTIR and DLS. Drug entrapment efficacy was up to 52%. Chitosan coated PLGA showed a pH responsive drug release in in vitro. The release was about 45% more at pH 5.5 than at pH 7.4. The results of our study indicated the development of chitosan coating over PLGA nanoparticle for pH dependent controlled release DS drug for therapeutic applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Drug Solubulity and Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Energy and Environmental Systems, North Carolina A & T State University, Greensboro, NC 27411, USA

Engineering Research Center Revolutionized Metallic Biomaterials, North Carolina A & T State University, Greensboro, NC 27411, USA

Department of Mechanical Engineering, North Carolina A & T State University, Greensboro, NC 27411, USA

Department of Chemical, Biological, and Bioengineering, North Carolina A & T State University, Greensboro, NC 27411, USA

Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Funding

National Science Foundation

References (39)

Show source-provided references
1. Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications10.1016/j.carbpol.2009.12.040 ↗
2. Fabrication and characterization of electrospun PCL-MgO-Keratin-Based composite nanofibers for biomedical applications10.3390/ma8074080 ↗
3. Biodegradable nanoparticles are excellent vehicle for site directed in vivo delivery of drugs and vaccines10.1186/1477-3155-9-55 ↗
4. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery10.1208/s12249-013-9943-3 ↗
5. Delivery systems for siRNA drug development in cancer therapy10.1016/j.ajps.2014.08.011 ↗
6. Nanoparticulate drug carriers based on hybrid poly(d,l-lactide-co-glycolide)-dendron structures10.1016/j.biomaterials.2006.04.026 ↗
7. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine10.2147/IJN.S70633 ↗
8. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis10.1073/pnas.96.13.7563 ↗
9. PLGA-based nanoparticles: An overview of biomedical applications10.1016/j.jconrel.2012.01.043 ↗
10. Direct determination of diclofenac in pharmaceutical formulations containing B vitamins by using UV spectrophotometry and partial least squares regression10.1016/j.jpba.2004.08.001 ↗
11. PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral10.1016/j.jconrel.2007.02.004 ↗
12. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone10.1007/s11095-009-9841-2 ↗
13. Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats10.1111/j.1476-5381.2009.00244.x ↗
14. Polymeric nanoparticles for cancer therapy10.1080/10611860701794353 ↗
15. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: Effect of the formulation parameters on complexation and transfection of antisense oligonucleotides10.1016/j.nano.2007.03.006 ↗
16. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate10.1080/10611860802088630 ↗
17. Adhikari, U., Rijal, N.P., Pai, D., Sankar, J., and Bhattarai, N. (2015, January 13–19). Synthesis and characterization of Chitosan-Mg-Based composite scaffolds for bone repair applications. Proceedings of the ASME 2015 International Mechanical Engineering Congress and Exposition, Houston, TX, USA.10.1115/IMECE2015-53082 ↗
18. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery10.1021/mp2005615 ↗
19. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review10.1016/S0142-9612(00)00126-5 ↗
20. Rijal, N.P., Adhikari, U., and Bhattarai, N. (2015, January 13–19). Magnesium incorporated polycaprolactone-based composite nanofibers. Proceedings of the ASME 2015 International Mechanical Engineering Congress and Exposition, Houston, TX, USA.10.1115/IMECE2015-53090 ↗
21. Chitosan-coated PLGA nanoparticles: A sustained drug release strategy for cell cultures10.1016/j.colsurfb.2012.10.063 ↗
22. Polysaccharide colloidal particles as delivery systems for macromolecules10.1016/S0169-409X(00)00123-X ↗
23. Effect of chitosan on epithelial permeability and structure10.1016/S0378-5173(99)00030-7 ↗
24. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles10.1016/j.ijpharm.2007.06.011 ↗
25. Efficient pH dependent drug delivery to target cancer cells by gold nanoparticles capped with carboxymethyl chitosan10.3390/ijms15058216 ↗
26. A Novel Approach to the Oral Delivery of Micro- or Nanoparticles10.1023/A:1015987516796 ↗
27. Design of microencapsulated chitosan microspheres for colonic drug delivery10.1016/S0168-3659(97)00203-4 ↗
28. Recent advances on chitosan-based micro- and nanoparticles in drug delivery10.1016/j.jconrel.2004.08.010 ↗
29. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices10.1016/S0142-9612(00)00115-0 ↗
30. The use of mucoadhesive polymers in ocular drug delivery10.1016/j.addr.2005.07.005 ↗
31. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery10.1016/j.nano.2009.10.004 ↗
32. Chitosan grafted methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac10.1038/srep11337 ↗
33. Pool, H., Quintanar, D., Figueroa, J.D., Mano, C.M., Bechara, E.J.H., Godinez, L.A., and Mendoza, S. (2012). Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles. J. Nanomater.10.1155/2012/145380 ↗
34. Chitosan/siloxane hybrid. polymer: Synthesis, characterization and performance as a support. for immobilizing enzyme10.1590/S0103-50532011000800003 ↗
35. Design and optimization of diclofenac sodium controlled release solid dispersions by response surface methodology10.4103/0250-474X.40327 ↗
36. Diclofenac sodium incorporated PLGA (50:50) microspheres: Formulation considerations and in vitro/in vivo evaluation10.1016/S0378-5173(99)00394-4 ↗
37. Erythropoietin loaded microspheres prepared from biodegradable LPLG–PEO–LPLG triblock copolymers: Protein stabilization and in vitro release properties10.1016/S0168-3659(98)00070-4 ↗
38. McCall, R.L., and Sirianni, R.W. (2013). PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. J. Vis. Exp.10.3791/51015-v ↗
39. Mathew, A., Fukuda, T., Nagaoka, Y., Hasumura, T., Morimoto, H., Yoshida, Y., Maekawa, T., Venugopal, K., and Kumar, D.S. (2012). Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer’s disease. PLoS ONE, 7.10.1371/journal.pone.0032616 ↗